United States Biotechnology & Medical Research

Rocket Pharmaceuticals Inc (RCKT)

Track

Over the past 90 days, Rocket Pharmaceuticals Inc. insiders have engaged in 19 transactions, resulting in a net negative value of approximately $276,192. All activity consisted of sales by executives, including CEO Gaurav Shah. These transactions occurred following the May 2026 earnings report, amid a 6.3% decline in the company's stock price.
Ticker: RCKT
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Rocket Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 7 Jul 2026
Value US$4,647,837.10 | Price 366.90 | Shares 97,329
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07 PrS Proposed sale
3.6
Malik Fady Ibraham

Director

Non-Executive Director
97,329
366.90
US$4,647,837 		97,329 366.90 US$4,647,837
2026-05-26 2026-05-21 S Sale
3.1
Shah Gaurav

CEO

Officer
55,967 -5.9%
442.48
US$3,732,557 		55,967 -5.9% 442.48 US$3,732,557
2026-05-21 2026-05-21 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
88,378
199.64
US$738,798 		88,378 199.64 US$738,798
2026-05-21 2026-05-21 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
55,684
3.09
US$171,821 		55,684 3.09 US$171,821
2026-05-21 2026-05-19 S Sale
4.2
Militello John

See Remarks

Officer
384 -0.4%
3.01
US$1,157 		384 -0.4% 3.01 US$1,157
2026-05-21 2026-05-19 S Sale
4.2
Militello John

See Remarks

Officer
384 -0.4%
3.01
US$1,157 		384 -0.4% 3.01 US$1,157
2026-05-21 2026-05-19 S Sale
4.0
Wilson Martin

General Counsel

Officer
662 -0.1%
3.01
US$1,995 		662 -0.1% 3.01 US$1,995
2026-05-21 2026-05-19 S Sale
3.1
Shah Gaurav

CEO

Officer
2,409 -0.2%
3.01
US$7,261 		2,409 -0.2% 3.01 US$7,261
2026-05-19 2026-05-19 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
2,409
3.01
US$7,262 		2,409 3.01 US$7,262
2026-05-19 2026-05-19 PrS Proposed sale
4.2
Militello John

Officer

Officer
384
3.01
US$1,158 		384 3.01 US$1,158
2026-05-19 2026-05-19 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
662
3.01
US$1,996 		662 3.01 US$1,996
2026-05-14 2026-05-13 S Sale
4.0
Wilson Martin

General Counsel

Officer
3,361 -0.5%
3.61
US$12,120 		3,361 -0.5% 3.61 US$12,120
2026-05-14 2026-05-13 S Sale
3.1
Shah Gaurav

CEO

Officer
2,728 -0.3%
3.61
US$9,837 		2,728 -0.3% 3.61 US$9,837
2026-05-14 2026-05-13 S Sale
4.2
Militello John

See Remarks

Officer
855 -0.9%
3.61
US$3,083 		855 -0.9% 3.61 US$3,083
2026-05-13 2026-05-13 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
3,361
3.61
US$12,118 		3,361 3.61 US$12,118
2026-05-13 2026-05-13 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
2,728
3.61
US$9,836 		2,728 3.61 US$9,836
2026-05-13 2026-05-13 PrS Proposed sale
4.2
Militello John

Officer

Officer
855
3.61
US$3,083 		855 3.61 US$3,083
2026-05-11 2026-05-07 S Sale
Chaudhuri Sarbani

See Remarks

Officer
17,650 -6.2%
3.84
US$67,741 		17,650 -6.2% 3.84 US$67,741
2026-05-07 2026-05-07 PrS Proposed sale
Chaudhuri Sarbani

Officer

Officer
17,650
3.84
US$67,741 		17,650 3.84 US$67,741
2026-02-20 2026-02-18 S Sale
4.2
Militello John

See Remarks

Officer
1,157 -1.3%
3.34
US$3,862 		1,157 -1.3% 3.34 US$3,862
2026-02-20 2026-02-18 S Sale
3.1
Shah Gaurav

CEO

Officer
5,990 -0.6%
3.34
US$19,995 		5,990 -0.6% 3.34 US$19,995
2026-02-20 2026-02-18 S Sale
4.0
Wilson Martin

General Counsel

Officer
1,376 -0.2%
3.34
US$4,593 		1,376 -0.2% 3.34 US$4,593
2026-02-18 2026-02-18 PrS Proposed sale
4.2
Militello John

Officer

Officer
1,157
3.34
US$3,863 		1,157 3.34 US$3,863
2026-02-18 2026-02-18 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
1,376
3.34
US$4,594 		1,376 3.34 US$4,594
2026-02-18 2026-02-18 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
5,990
3.34
US$19,998 		5,990 3.34 US$19,998
2026-02-18 2026-02-13 S Sale
4.0
Wilson Martin

General Counsel

Officer
12,253 -1.8%
3.31
US$40,582 		12,253 -1.8% 3.31 US$40,582
2026-02-18 2026-02-13 S Sale
4.2
Militello John

See Remarks

Officer
3,726 -3.9%
3.31
US$12,341 		3,726 -3.9% 3.31 US$12,341
2026-02-18 2026-02-13 S Sale
3.1
Shah Gaurav

CEO

Officer
12,279 -1.2%
3.31
US$40,668 		12,279 -1.2% 3.31 US$40,668
2026-02-13 2026-02-13 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
12,253
3.31
US$40,583 		12,253 3.31 US$40,583
2026-02-13 2026-02-13 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
14,508
3.31
US$48,052 		14,508 3.31 US$48,052
2026-02-13 2026-02-13 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
12,279
3.31
US$40,669 		12,279 3.31 US$40,669
2026-02-13 2026-02-13 PrS Proposed sale
4.2
Militello John

Officer

Officer
3,726
3.31
US$12,341 		3,726 3.31 US$12,341
2026-01-06 2026-01-02 B Purchase
2.5
Bjork Elisabeth
Non-Executive Director
10,000 +25.0%
3.44
US$34,400 		10,000 +25.0% 3.44 US$34,400
2025-11-20 2025-11-18 S Sale
4.0
Schwartz Jonathan David

See Remarks

Officer
2,545 -0.8%
2.98
US$7,592 		2,545 -0.8% 2.98 US$7,592
2025-11-20 2025-11-18 S Sale
4.0
Wilson Martin

General Counsel

Officer
1,646 -0.4%
2.98
US$4,910 		1,646 -0.4% 2.98 US$4,910
2025-11-20 2025-11-18 S Sale
4.2
Militello John

See Remarks

Officer
1,086 -1.6%
2.98
US$3,240 		1,086 -1.6% 2.98 US$3,240
2025-11-20 2025-11-18 S Sale
3.1
Shah Gaurav

CEO

Executive Director
6,276 -0.8%
2.98
US$18,721 		6,276 -0.8% 2.98 US$18,721
2025-11-18 2025-11-18 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
2,545
2.98
US$7,591 		2,545 2.98 US$7,591
2025-11-18 2025-11-18 PrS Proposed sale
3.1
Shah Gaurav

Officer; Director

Executive Director
6,276
2.98
US$18,720 		6,276 2.98 US$18,720
2025-11-18 2025-11-18 PrS Proposed sale
4.2
Militello John

Officer

Officer
1,086
2.98
US$3,239 		1,086 2.98 US$3,239
2025-11-18 2025-11-18 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
1,646
2.98
US$4,910 		1,646 2.98 US$4,910
2025-10-16 2025-10-14 S Sale
4.2
Militello John

See Remarks

Officer
558 -0.8%
3.98
US$2,218 		558 -0.8% 3.98 US$2,218
2025-10-16 2025-10-14 S Sale
4.2
Militello John

See Remarks

Officer
3,005 -4.3%
3.97
US$11,930 		3,005 -4.3% 3.97 US$11,930
2025-10-16 2025-10-14 S Sale
4.2
Militello John

See Remarks

Officer
5,514 -7.2%
3.97
US$21,863 		5,514 -7.2% 3.97 US$21,863
2025-10-16 2025-10-14 S Sale
4.2
Militello John

See Remarks

Officer
19,841 -20.7%
3.96
US$78,570 		19,841 -20.7% 3.96 US$78,570
2025-10-14 2025-10-14 PrS Proposed sale
4.2
Militello John

Officer

Officer
28,918
3.96
US$114,581 		28,918 3.96 US$114,581
2025-08-27 2025-08-27 B Purchase
2.5
Bjork Elisabeth
Non-Executive Director
10,000 +33.3%
3.41
US$34,100 		10,000 +33.3% 3.41 US$34,100
2025-08-20 2025-08-19 S Sale
4.0
Schwartz Jonathan David

See Remarks

Officer
805 -0.4%
3.00
US$2,412 		805 -0.4% 3.00 US$2,412
2025-08-20 2025-08-19 S Sale
4.0
Wilson Martin

General Counsel

Officer
588 -0.4%
3.00
US$1,762 		588 -0.4% 3.00 US$1,762
2025-08-20 2025-08-19 S Sale
4.2
Militello John

See Remarks

Officer
361 -0.6%
3.00
US$1,082 		361 -0.6% 3.00 US$1,082
2025-08-19 2025-08-19 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
588
3.00
US$1,762 		588 3.00 US$1,762
2025-08-19 2025-08-19 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
805
3.00
US$2,412 		805 3.00 US$2,412
2025-08-19 2025-08-19 PrS Proposed sale
4.2
Militello John

Officer

Officer
361
3.00
US$1,082 		361 3.00 US$1,082
2025-08-20 2025-08-18 S Sale
4.0
Schwartz Jonathan David

See Remarks

Officer
1,680 -0.7%
3.07
US$5,149 		1,680 -0.7% 3.07 US$5,149
2025-08-20 2025-08-18 S Sale
4.0
Wilson Martin

General Counsel

Officer
1,004 -0.7%
3.07
US$3,077 		1,004 -0.7% 3.07 US$3,077
2025-08-20 2025-08-18 S Sale
4.2
Militello John

See Remarks

Officer
699 -1.2%
3.07
US$2,142 		699 -1.2% 3.07 US$2,142
2025-08-18 2025-08-18 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
1,004
3.07
US$3,077 		1,004 3.07 US$3,077
2025-08-18 2025-08-18 PrS Proposed sale
4.2
Militello John

Officer

Officer
699
3.07
US$2,143 		699 3.07 US$2,143
2025-08-18 2025-08-18 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
1,680
3.07
US$5,150 		1,680 3.07 US$5,150
2025-08-18 2025-08-14 S Sale
4.0
Wilson Martin

General Counsel

Officer
12,109 -8.1%
3.02
US$36,557 		12,109 -8.1% 3.02 US$36,557
2025-08-18 2025-08-14 S Sale
4.2
Militello John

See Remarks

Officer
7,043 -11.0%
3.02
US$21,263 		7,043 -11.0% 3.02 US$21,263
2025-08-18 2025-08-14 S Sale
4.0
Schwartz Jonathan David

See Remarks

Officer
11,161 -4.7%
3.02
US$33,695 		11,161 -4.7% 3.02 US$33,695
2025-08-14 2025-08-14 PrS Proposed sale
4.2
Militello John

Officer

Officer
7,043
3.02
US$21,261 		7,043 3.02 US$21,261
2025-08-14 2025-08-14 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
12,109
3.02
US$36,553 		12,109 3.02 US$36,553
2025-08-14 2025-08-14 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
11,161
3.02
US$33,692 		11,161 3.02 US$33,692
2025-07-08 2025-07-03 S Sale
2.6
Ondrey Aaron

Chief Financial Officer

Officer
1,477 -1.1%
2.88
US$4,257 		1,477 -1.1% 2.88 US$4,257
2025-07-03 2025-07-03 PrS Proposed sale
2.6
Ondrey Aaron

Officer

Officer
1,477
2.88
US$4,256 		1,477 2.88 US$4,256
2025-05-22 2025-05-20 S Sale
4.0
Wilson Martin

General Counsel

Officer
587 -0.4%
6.45
US$3,784 		587 -0.4% 6.45 US$3,784
2025-05-22 2025-05-20 S Sale
3.1
Shah Gaurav

CEO

Executive Director
2,253 -0.3%
6.45
US$14,523 		2,253 -0.3% 6.45 US$14,523
2025-05-22 2025-05-20 S Sale
3.9
Patel Kinnari

See Remarks

Officer
767 -0.2%
6.45
US$4,944 		767 -0.2% 6.45 US$4,944
2025-05-22 2025-05-20 S Sale
4.0
Schwartz Jonathan David

See Remarks

Officer
801 -0.3%
6.45
US$5,163 		801 -0.3% 6.45 US$5,163
2025-05-22 2025-05-20 S Sale
4.2
Militello John

See Remarks

Officer
357 -0.6%
6.45
US$2,301 		357 -0.6% 6.45 US$2,301
2025-05-20 2025-05-20 PrS Proposed sale
4.0
Wilson Martin

Officer

Officer
587
6.45
US$3,784 		587 6.45 US$3,784
2025-05-20 2025-05-20 PrS Proposed sale
4.2
Militello John

Officer

Officer
357
6.45
US$2,301 		357 6.45 US$2,301
2025-05-20 2025-05-20 PrS Proposed sale
4.0
Schwartz Jonathan David

Officer

Officer
801
6.45
US$5,163 		801 6.45 US$5,163
Explore more

More insider trading research around Rocket Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America